| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/11/2004 | CN1520284A Anorexic compsn. comprising calcium acetate |
| 08/11/2004 | CN1520256A Use of follistatin to increase muscle mass |
| 08/11/2004 | CN1519227A Zine chelated amino acid as well as its preparation and application |
| 08/11/2004 | CN1519031A Biological preparation modified in plasma environment for treating diabetes and preparation method |
| 08/11/2004 | CN1519024A Slim foodstuff for fat female containing microzyme modified in plasma environment |
| 08/11/2004 | CN1518991A Soft capsule of meat and bone meal of fur seal, preparation method and usage |
| 08/11/2004 | CN1518989A Soft capsule of fur seal and application in preparing health products for regulating blood fat |
| 08/11/2004 | CN1518974A Chawing tablet containing beta carotene |
| 08/11/2004 | CN1518896A Slim foodstuff for common female containing microzyme modified in plasma environment |
| 08/11/2004 | CN1518895A Slim foodstuff for fat male containing microzyme modified in plasma environment |
| 08/11/2004 | CN1518894A Slim foodstuff for common male containing microzyme modified in plasma environment |
| 08/11/2004 | CN1161465C Chimeric proteins for use in transport of selected substance into cells |
| 08/11/2004 | CN1161356C Puring inhibitors of cylin dependent kinase 2 and I'kappa'beta-'alpha' |
| 08/11/2004 | CN1161352C Quinazoline derivatives |
| 08/11/2004 | CN1161345C 1,5-benzodiazepine derivatives ad CCK-A receptor agonists |
| 08/11/2004 | CN1161338C Fluorinated 3,4-dihydroquinoline derivatives used and NOS inhibitors |
| 08/11/2004 | CN1161314C E-2-[4-(4-chloro-1,2-diphenyl-but-1-enyl) phenoxyl] ethanol and pharmaceutical compositions thereof |
| 08/11/2004 | CN1161146C Chinese medicine for treating coronary heart disease, reducing blood fat and improving sleep and its preparing process |
| 08/11/2004 | CN1161144C Elmination of toxicant and fat-lowering capsule and its preparation technology |
| 08/11/2004 | CN1161140C Medicine for preventing and treating coronary heart disease and angina pectoris and its prepn and other use |
| 08/11/2004 | CN1161136C Konjaku capsule for treating type-II diabetes |
| 08/11/2004 | CN1161120C Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylasis treatment of obesity |
| 08/11/2004 | CN1161118C Use of 5HT3 receptor antagouists for the treatment of chronic fatigue syndrome |
| 08/11/2004 | CN1161036C Compsns. containing creatine in suspension |
| 08/11/2004 | CA2457460A1 Implantable medical device seeded with mammalian cells and methods of treatment |
| 08/10/2004 | US6774142 May be administered along with rutin, a rutin congener and/or a rutin derivative. |
| 08/10/2004 | US6774136 Substituted 1 and 2 naphthol mannich bases |
| 08/10/2004 | US6774132 Spirooxindole derivatives that act as analgesics |
| 08/10/2004 | US6774128 Administering to the mammal a therapeutically effective amount of a compound that increases nitric oxide (no) activity as measured in a standard gastric emptying assay |
| 08/10/2004 | US6774127 Pyrazole and pyrazoline substituted compounds |
| 08/10/2004 | US6774120 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 08/10/2004 | US6774112 Antidiabetic agents; cardiovascular disorders |
| 08/10/2004 | US6774111 Carbohydrate system and a method for providing nutrition to a diabetic |
| 08/10/2004 | US6773716 Over-coated chewing gum formulations |
| 08/10/2004 | US6773715 Preparation and use of solidified oils |
| 08/10/2004 | US6773708 Suppression of excessive th1 and stimulation of th2 cell mediated immune responses |
| 08/10/2004 | CA2306008C Composition for and method of reducing low density lipoprotein cholesterol concentration |
| 08/10/2004 | CA2145501C Method for treatment or prevention of obesity |
| 08/10/2004 | CA2136238C Renewal of extrinsic aging of the skin by transdermal application of selenoamino acids |
| 08/05/2004 | WO2004065960A1 Novel screening method |
| 08/05/2004 | WO2004065380A1 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 08/05/2004 | WO2004065372A1 Tetrazole-functionalized amino acids, their production and use |
| 08/05/2004 | WO2004065350A1 Tertiary amino acids, their production and use |
| 08/05/2004 | WO2004064862A1 Long acting insulin for reducing cardiovascular morbidity and mortality in prediabetic patients and patients with type 2 diabetes |
| 08/05/2004 | WO2004064856A2 Proteins involved in the regulation of energy homeostasis |
| 08/05/2004 | WO2004064840A1 Composition for treting hyperlipemia |
| 08/05/2004 | WO2004064831A1 Compounds having anti-proliferative properties |
| 08/05/2004 | WO2004064830A1 Processed fat compositions for preventing and improving lifestyle-related diseases |
| 08/05/2004 | WO2004064825A1 Preventive or remedy for intrauterine late embryonic development or pregnancy toxemia |
| 08/05/2004 | WO2004064764A2 Substituted alkyl amido piperidines |
| 08/05/2004 | WO2004064742A2 Methods and compositions for p2x receptor calcium entry channels and other calcium entry mechanisms |
| 08/05/2004 | WO2004064542A1 Composition for oral administration containing capsaicinoids |
| 08/05/2004 | WO2004041257A3 Novel nutraceutical compositions comprising epigallocatechin gallate |
| 08/05/2004 | WO2004037169A3 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 08/05/2004 | WO2004029192A3 Producing method of tien hsien liquid |
| 08/05/2004 | WO2004022716A9 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 08/05/2004 | WO2004010974A3 Gelatin capsule exhibiting reduced cross-linking |
| 08/05/2004 | WO2004010973A3 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage |
| 08/05/2004 | WO2003086288A3 Bicyclic amides |
| 08/05/2004 | WO2003070204A3 Lipase inhibiting composition |
| 08/05/2004 | WO2003059289A3 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues |
| 08/05/2004 | WO2003042359A3 Histamine receptor h3 polynucleotides |
| 08/05/2004 | WO2003037165A3 System and method for the pretreatment of the endplates of an intervertebral disc |
| 08/05/2004 | WO2003007689A3 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 08/05/2004 | US20040152906 Sulfonamides |
| 08/05/2004 | US20040152901 Hydrochloride salts of 5-[4-[2-(n-methyl-n-(2-pyridyl) amino)ethoxy]benzyl]thiazolidine-2,4-dione |
| 08/05/2004 | US20040152893 Sulfonamides |
| 08/05/2004 | US20040152891 Sulfonamides |
| 08/05/2004 | US20040152888 novel benzodiazepine derivatives |
| 08/05/2004 | US20040152779 Bicyclic amino acids as pharmaceutical agents |
| 08/05/2004 | US20040152771 Mixture with biguanidine drug; antidiabetic agents; insulin resistance |
| 08/05/2004 | US20040152761 Dimeric isoflavones |
| 08/05/2004 | US20040152754 Cyclic AMP-specific phosphodiesterase inhibitors |
| 08/05/2004 | US20040152751 Viricides; suppress lymphocytes; aids therapy; antiinflammatory agents |
| 08/05/2004 | US20040152744 Phenylacetic acid derivative; hypoglycemic agents; antilipemic agents; antichoilesterol agents; cardiovascular disorders |
| 08/05/2004 | US20040152743 Heterocyclically substituted benzoylureas, process for their preparation and their use as pharmaceuticals |
| 08/05/2004 | US20040152692 Pyrrolidine sulfonamides |
| 08/05/2004 | US20040152681 Interact with nuclear liver X receptor (LXR) and ubiquitous receptor (UR) and can be used to treat a variety of LXR- or UR-mediated disorders |
| 08/05/2004 | US20040152680 Treating autoimmune diseases, skin disorders, malignancies |
| 08/05/2004 | US20040152679 (20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 08/05/2004 | US20040152678 Administering 20S)-1 alpha -hydroxy-2 alpha -methyl-19-nor-vitamin D3 for therapy of psoriasis |
| 08/05/2004 | US20040152677 (20S)-1alpha-hydroxy-2alpha-methl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 08/05/2004 | US20040152676 (20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 08/05/2004 | US20040152675 (20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 08/05/2004 | US20040152665 Administering to mammal an effective amount of a N-acylated-2-glucosamine derivative for enhancing weight gain or growth of a mammal exhibiting decreased weight or growth |
| 08/05/2004 | US20040152652 Therapy of inflammatory disorder in an individual comprising administering oligonucleotide up to 30 nucleotides in length complementary to a nucleic acid molecule encoding human tumor necrosis factor- alpha |
| 08/05/2004 | US20040152641 Use of polymethoxylated flavones for treating insulin resistance |
| 08/05/2004 | US20040152157 G-protein coupled receptors |
| 08/05/2004 | US20040152078 Genetic engineering |
| 08/05/2004 | US20040151786 Pharmaceutical and/or cosmetic compositions for the treatment of localised adiposities and cellulite |
| 08/05/2004 | US20040151781 Osteoporosis, hormone-related disorders |
| 08/05/2004 | US20040151687 Poly(diallylamine)-based bile acid sequestrants |
| 08/05/2004 | DE10301371A1 Treatment or prophylaxis of cardiovascular, cardiopulmonary or renal diseases, e.g. hypertension combined with hyperlipidemia or atherosclerosis, using combination of telmisartan and atorvastatin |
| 08/05/2004 | DE10261067A1 Cholesterinsenkendes Mittel, enthaltend eine n-3-Fettsäure Cholesterol-lowering agents containing an n-3 fatty acid |
| 08/05/2004 | CA2513616A1 Composition for oral administration containing capsaicinoids |
| 08/05/2004 | CA2513606A1 Preventive or remedy for intrauterine late embryonic development or pregnancy toxemia |
| 08/05/2004 | CA2512899A1 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 08/05/2004 | CA2509456A1 Substituted alkyl amido piperidines |
| 08/04/2004 | EP1443110A2 Human VEGF-specific antisense oligonucleotides |
| 08/04/2004 | EP1443106A1 Somatic cell derived embryonic stem cells and its differentiated cells |